CHD2 and meningioma: Novel somatic driver events identified in these meningiomas were chromatin remodeling and mutations in epigenetic regulators lysine demethylase 6A (KDM6A), chromodomain helicase DNA binding protein 2 (CHD2), and tumor suppressor phosphatase and tensin homolog (PTEN).